Schubert & Co Raises Holdings in Danaher Corporation (NYSE:DHR)

Schubert & Co increased its position in Danaher Corporation (NYSE:DHR) by 0.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,648 shares of the conglomerate’s stock after purchasing an additional 118 shares during the period. Danaher makes up 5.6% of Schubert & Co’s investment portfolio, making the stock its 4th largest holding. Schubert & Co’s holdings in Danaher were worth $8,128,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. GHP Investment Advisors Inc. lifted its stake in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares in the last quarter. Heck Capital Advisors LLC bought a new position in Danaher during the 4th quarter valued at $27,000. Sierra Ocean LLC lifted its stake in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new position in Danaher during the 1st quarter valued at $31,000. Finally, Hurley Capital LLC purchased a new stake in shares of Danaher during the 4th quarter valued at $34,000. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. TD Cowen boosted their price target on shares of Danaher from $240.00 to $248.00 and gave the stock a “buy” rating in a report on Wednesday, April 23rd. Wolfe Research cut their price target on shares of Danaher from $275.00 to $220.00 and set an “outperform” rating on the stock in a report on Monday, April 7th. Leerink Partners boosted their price target on shares of Danaher from $225.00 to $230.00 and gave the stock an “outperform” rating in a report on Wednesday, April 23rd. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Finally, UBS Group cut their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a report on Wednesday, July 23rd. Three equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $247.61.

Danaher Stock Up 1.4%

DHR stock opened at $205.60 on Monday. The company’s 50 day moving average is $196.38 and its 200 day moving average is $203.44. The stock has a market cap of $147.22 billion, a price-to-earnings ratio of 43.74, a price-to-earnings-growth ratio of 2.86 and a beta of 0.77. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the company posted $1.72 EPS. Sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 25th. Stockholders of record on Friday, June 27th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Insider Buying and Selling at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the company’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares of the company’s stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president directly owned 15,179 shares of the company’s stock, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.20% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.